Lung cancer "poorly differentiated adenocarcinoma"
Hello! The earlier you start, the better the effect. A. Surgical treatment: As the main treatment at present, about half of early lung cancer can survive for a long time after operation. Therefore, unless there is extensive infiltration, distant metastasis, or the patient's general condition does not allow it, every effort should be made to remove the lesion, clean the lymph nodes metastasized in the mediastinum, and preserve healthy lung tissue as much as possible. Lobectomy is generally the first choice for peripheral lung cancer, and pneumonectomy is often needed for central lung cancer. B radiotherapy: the sensitivity was undifferentiated carcinoma, squamous cell carcinoma, adenocarcinoma and bronchioloalveolar cell carcinoma in turn. The 3-year survival rate of radiotherapy alone is about 10%. Preoperative and postoperative radiotherapy can improve the surgical effect, and palliative radiotherapy can relieve symptoms in advanced cases. Chemotherapy: cyclophosphamide, 5- fluorouracil, vincristine, thiotepa, etc. They are commonly used, and have certain curative effect on poorly differentiated large cell lung cancer, especially undifferentiated oat cell cancer. D. immunotherapy: treated somatic tumor cells or adjuvants can be used for subcutaneous inoculation (specific immunotherapy); BCG, Corynebacterium parvum, transfer factor, interferon, levamisole, etc. You can also choose to enhance the body's immune function (nonspecific immunotherapy). Affiliated Hospital of Shandong University of Traditional Chinese Medicine-Pulmonary Diseases Department-Chief Physician Zhang Wei View the original >>